Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSISTENT study of NPL insulin suspension versus insulin glargine in adults with type 2 diabetes mellitus
2007-002418-20Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Humalog NPL arm with Lantus arm (2 arms). Primary endpoint: Change in hemoglobin A1c from baseline to 24 weeks. Started Jun 2007; status: completed.
02
Drugs
insulin lispro protamineinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-002418-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002418-20.